Article Text

Download PDFPDF
SARS-CoV-2 infection triggering recurrence of Kawasaki disease in a 10-year-old child
  1. Ashok Renganathan1,
  2. Ankit Garg2,
  3. Sona Chowdhary1 and
  4. Dinesh Raj1
  1. 1Department of Pediatrics, Holy Family Hospital, New Delhi, India
  2. 2Department of Pediatric Cardiology, Fortis Escorts Heart Institute and Research Centre, New Delhi, India
  1. Correspondence to Dr Dinesh Raj; dr_aiims{at}yahoo.co.in

Abstract

SARS-CoV-2 infection has recently been related to a spectrum of hyper-inflammatory states in children. There is a striking similarity between these hyper-inflammatory states and Kawasaki disease (KD). We present an interesting case of KD recurrence in a 10-year-old child, who had previously developed KD at 4 years of age. His symptoms included fever, maculopapular rash and altered sensorium. Investigations showed noticeably elevated inflammatory markers, and an echocardiography revealed dilated coronary arteries. SARS-CoV-2 IgG antibodies were positive. The child responded dramatically to intravenous immunoglobulin and intravenous methylprednisolone. It is possible that SARS-CoV-2 infection triggered the recurrence of KD in this child who might have been genetically predisposed to KD.

  • COVID-19
  • infectious diseases
  • paediatrics
  • rheumatology

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @infectious disease

  • Contributors AR and DR: literature review. AR, SC and DR: manuscript writing. AR, AG and SC: clinical management of the patient. AG: provided paediatric cardiology support.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.